MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics (Q37983956)

26 August 2017

MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics (English)

1 reference

26 August 2017

0 references

1 reference

1 reference

A Gordanpour

1

1 reference

26 August 2017

R K Nam

series ordinal

2

1 reference

26 August 2017

L Sugar

series ordinal

3

1 reference

26 August 2017

A Seth

series ordinal

4

1 reference

26 August 2017

14 February 2012

1 reference

Prostate Cancer and Prostatic Diseases

26 August 2017

1 reference

26 August 2017

15

1 reference

26 August 2017

4

1 reference

26 August 2017

314-319

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2012.3

26 August 2017

0 references

cites work

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

miR-148 targets human DNMT3b protein coding region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Transcriptional control of gene expression by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Mechanistic principles of chromatin remodeling guided by siRNAs and miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

MicroRNA-directed transcriptional gene silencing in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

miRBase: integrating microRNA annotation and deep-sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Most mammalian mRNAs are conserved targets of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

The microRNA.org resource: targets and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Combinatorial microRNA target predictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Prediction of mammalian microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

MicroRNAs modulate hematopoietic lineage differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

The Drosophila MicroRNA Mir-14 Suppresses Cell Death and Is Required for Normal Fat Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Control of cell proliferation pathways by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

MicroRNA expression profiling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Metastamir: the field of metastasis-regulatory microRNA is spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

MicroRNAs associated with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Loss of mir-146a function in hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

A study of miRNAs targets prediction and experimental validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

The road toward microRNA therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Targeting microRNAs in cancer: rationale, strategies and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Promise and challenge of RNA interference-based therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

The promise of microRNA replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Gene delivery by cationic lipid vectors: overcoming cellular barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

MicroRNA profile analysis of human prostate cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.3

31 March 2020

Identifiers

DOI

10.1038/PCAN.2012.3

1 reference

26 August 2017

1 reference